SL-251131

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSL-251131
Drug Alias NameSL-251131
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitorsMonoamine oxidase A inhibitors
TargetsMonoamine oxidase AMonoamine oxidase B
Therapy Area/IndicationsDepressive Disorder, MajorParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A